VITA 34 AG

XTRA:V3V Stock Report

Market Cap: €70.8m

VITA 34 Management

Management criteria checks 2/4

VITA 34's CEO is Jakub Baran, appointed in Mar 2022, has a tenure of 2.83 years. directly owns 2.9% of the company’s shares, worth €2.05M. The average tenure of the management team and the board of directors is 2.8 years and 4.5 years respectively.

Key information

Jakub Baran

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownership2.9%
Management average tenure2.8yrs
Board average tenure4.5yrs

Recent management updates

VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Dec 07
VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

How Is VITA 34's (ETR:V3V) CEO Compensated?

Dec 18
How Is VITA 34's (ETR:V3V) CEO Compensated?

Recent updates

Why We're Not Concerned About VITA 34 AG's (ETR:V3V) Share Price

Apr 04
Why We're Not Concerned About VITA 34 AG's (ETR:V3V) Share Price

Revenues Tell The Story For VITA 34 AG (ETR:V3V) As Its Stock Soars 26%

Dec 24
Revenues Tell The Story For VITA 34 AG (ETR:V3V) As Its Stock Soars 26%

Is VITA 34 (ETR:V3V) Using Too Much Debt?

Nov 23
Is VITA 34 (ETR:V3V) Using Too Much Debt?

Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Jul 15
Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Feb 17
Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Apr 08
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Dec 07
VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

May 12
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Earnings Miss: VITA 34 AG Missed EPS By 29% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: VITA 34 AG Missed EPS By 29% And Analysts Are Revising Their Forecasts

VITA 34 AG's (ETR:V3V) Intrinsic Value Is Potentially 56% Above Its Share Price

Mar 25
VITA 34 AG's (ETR:V3V) Intrinsic Value Is Potentially 56% Above Its Share Price

Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Mar 10
Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Here's Why VITA 34 (ETR:V3V) Can Manage Its Debt Responsibly

Feb 22
Here's Why VITA 34 (ETR:V3V) Can Manage Its Debt Responsibly

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Feb 05
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Can Mixed Financials Have A Negative Impact on VITA 34 AG's 's (ETR:V3V) Current Price Momentum?

Jan 18
Can Mixed Financials Have A Negative Impact on VITA 34 AG's 's (ETR:V3V) Current Price Momentum?

Did You Participate In Any Of VITA 34's (ETR:V3V) Fantastic 201% Return ?

Jan 02
Did You Participate In Any Of VITA 34's (ETR:V3V) Fantastic 201% Return ?

How Is VITA 34's (ETR:V3V) CEO Compensated?

Dec 18
How Is VITA 34's (ETR:V3V) CEO Compensated?

Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Dec 01
Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

CEO

Jakub Baran

2.8yrs

Tenure

Mr. Jakub Julian Baran serves as Chairman of the Management Board and Chief Executive Officer at VITA 34 AG since March 22, 2022. He serves as Member of the Supervisory Board at Betacom S.A. since May 2019...

Leadership Team

NamePositionTenureCompensationOwnership
Jakub Baran
Chairman of the Management Board & CEO2.8yrsno data2.9%
€ 2.1m
Tomasz Baran
Vice President of the Management Board & Chief Commercial Officer2.8yrsno data0.70%
€ 498.6k
Thomas Pfaadt
Chief Financial Officer1yrno datano data
Santiago Luengo
Managing Director of Secuvitano datano datano data

2.8yrs

Average Tenure

Experienced Management: V3V's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Isadore Ances
Member of Scientific & Medical Advisory Boardno datano datano data
A. Bader
Member of Scientific & Medical Advisory Boardno datano datano data
Robert Iannone
Member of Scientific & Medical Advisory Boardno datano datano data
W. Holzgreve
Member of Scientific & Medical Advisory Boardno datano datano data
Carlo Croce
Member of Scientific & Medical Advisory Boardno datano datano data
Jack Goldberg
Member of Scientific & Medical Advisory Boardno datano datano data
E. Wunder
Member of Scientific & Medical Advisory Boardno datano datano data
Ronald Wapner
Member of Scientific & Medical Advisory Boardno datano datano data
Zbigniew Mrowiec
Member of Scientific & Medical Advisory Boardno datano datano data
Florian Schuhbauer
Deputy Chairman of the Supervisory Board4.5yrs€20.00kno data
Alexander Granderath
Chairman of Supervisory Board3.1yrsno datano data
Frank Kohler
Independent Member of the Supervisory Board7.6yrs€30.00kno data

4.5yrs

Average Tenure

Experienced Board: V3V's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 06:04
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

VITA 34 AG is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emily HainesFirst Berlin Equity Research GmbH
Tim KruseMontega AG
IGOR KIMOddo Seydler